The Food and Drug Administration is currently investigating a reported link between breast implants and a rare form of cancer called anaplastic large cell lymphoma.

According to, the FDA has investigated the possibility for the past 13 years, during which time they have discovered 60 cases of the cancer in scar tissue formed after a breast implant surgery.

Anaplastic large cell lymphoma (ALCL) is present in females with both saline and silicone implants. 60 cases out of the approximately 10 million women with breast implants is not a large number, but the link is present, says the FDA.

Current research on ALCL does not prove a link between breast implants and cancer, but the Fda did go on record as saying that the “”data reviewed by the FDA suggest that patients with breast implants may have a very small but significant risk of ALCL in the scar capsule adjacent to the implant.”

Allergan Inc. (AGN) and Mentor Worldwide LLC, a subsidiary of Johnson & Johnson (JNJ) are the primary producers of breast implants in the United States.

When questioned a spokesman for Mentor stated that the establishment “fully supports FDA’s efforts to gather additional information and study ALCL in patients with breast implants.”